These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 769632)

  • 1. Normal disposition of oxazepam in acute viral hepatitis and cirrhosis.
    Shull HJ; Wilkinson GR; Johnson R; Schenker S
    Ann Intern Med; 1976 Apr; 84(4):420-5. PubMed ID: 769632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of oxazepam and lorazepam.
    Greenblatt DJ
    Clin Pharmacokinet; 1981; 6(2):89-105. PubMed ID: 6111408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of liver disease in man on the disposition of phenobarbital.
    Alvin J; McHorse T; Hoyumpa A; Bush MT; Schenker S
    J Pharmacol Exp Ther; 1975 Jan; 192(1):224-35. PubMed ID: 235636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives.
    Abernethy DR; Greenblatt DJ; Ochs HR; Weyers D; Divoll M; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1983 May; 33(5):628-32. PubMed ID: 6132698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam.
    Patel M; Tang BK; Grant DM; Kalow W
    Pharmacogenetics; 1995 Oct; 5(5):287-97. PubMed ID: 8563769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
    Klotz U; Avant GR; Hoyumpa A; Schenker S; Wilkinson GR
    J Clin Invest; 1975 Feb; 55(2):347-59. PubMed ID: 1127104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of liver disease and of aging on the disposition and elimination of sedatives.
    Schenker S
    Trans Am Clin Climatol Assoc; 1978; 89():91-9. PubMed ID: 30206
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlordiazepoxide and oxazepam disposition in cirrhosis.
    Sellers EM; Greenblatt DJ; Giles HG; Naranjo CA; Kaplan H; MacLeod SM
    Clin Pharmacol Ther; 1979 Aug; 26(2):240-6. PubMed ID: 455893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal disease, age, and oxazepam kinetics.
    Murray TG; Chiang ST; Koepke HH; Walker BR
    Clin Pharmacol Ther; 1981 Dec; 30(6):805-9. PubMed ID: 7307429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative versus conjugative biotransformation of temazepam.
    Locniskar A; Greenblatt DJ
    Biopharm Drug Dispos; 1990; 11(6):499-506. PubMed ID: 2207300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of liver dysfunction on the pharmacokinetics of carprofen.
    Holazo AA; Chen SS; McMahon FG; Ryan JR; Konikoff JJ; Brazzell RK
    J Clin Pharmacol; 1985 Mar; 25(2):109-14. PubMed ID: 3886707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxazepam disposition in uremic patients.
    Odar-Cederlöf I; Vessman J; Alván G; Sjöqvist F
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):52-62. PubMed ID: 300542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of oxazepam in patients on maintenance hemodialysis.
    Ochs HR; Greenblatt DJ; Klehr U
    Klin Wochenschr; 1984 Aug; 62(16):765-7. PubMed ID: 6482312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of age and chronic liver disease on the elimination of temazepam.
    Ghabrial H; Desmond PV; Watson KJ; Gijsbers AJ; Harman PJ; Breen KJ; Mashford ML
    Eur J Clin Pharmacol; 1986; 30(1):93-7. PubMed ID: 2872062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam and lorazepam in man.
    Wilkinson GR
    Acta Psychiatr Scand Suppl; 1978; (274):56-74. PubMed ID: 32740
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetics and dynamics of single doses of oxazepam in the elderly: implications of absorption rate.
    Dreyfuss D; Shader RI; Harmatz JS; Greenblatt DJ
    J Clin Psychiatry; 1986 Oct; 47(10):511-4. PubMed ID: 3759915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of liver disease on the disposition of ciramadol in humans.
    Hoyumpa AM; Brown MW; Johnson R; Troxell R; Snowdy P; Schenker S
    J Clin Pharmacol; 1989 Mar; 29(3):217-24. PubMed ID: 2723108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cimetidine spares the glucuronidation of lorazepam and oxazepam.
    Patwardhan RV; Yarborough GW; Desmond PV; Johnson RF; Schenker S; Speeg KV
    Gastroenterology; 1980 Nov; 79(5 Pt 1):912-6. PubMed ID: 6106621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetic profile of oxazepam.
    Alván G; Odar-Cederlöf I
    Acta Psychiatr Scand Suppl; 1978; (274):47-55. PubMed ID: 282777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen.
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Lab Clin Med; 1983 Jun; 101(6):873-80. PubMed ID: 6133901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.